Klaus EDVARDSEN

Person

Klampenborg, DK

People

Patents Grantslast 30 patents

Information Patent Grant
Methods and antibodies for treating cancer
- Patent number 9,540,450
- Issue date Jan 10, 2017
- Genmab A/S
- Jan Van De Winkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating rash in patients undergoing anti-EGFR therapy
- Patent number 9,428,582
- Issue date Aug 30, 2016
- Genmab A/S
- Klaus Edvardsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functionalized stilbene derivatives as improved vascular targeting...
- Patent number RE45907
- Issue date Mar 1, 2016
- OXiGENE, Inc.
- David J. Chaplin
- 001 -
Information Patent Grant
Functionalized stilbene derivatives as improved vascular targeting...
- Patent number RE45720
- Issue date Oct 6, 2015
- OXiGENE, Inc.
- David J. Chaplin
- 001 -
Information Patent Grant
Functionalized stilbene derivatives as improved vascular targeting...
- Patent number 7,384,925
- Issue date Jun 10, 2008
- OXiGENE, Inc.
- David J. Chaplin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tubulin binding ligands and corresponding prodrug constructs
- Patent number 7,091,240
- Issue date Aug 15, 2006
- Oxigene, Inc.
- Kevin G. Pinney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tubulin binding agents and corresponding prodrug constructs
- Patent number 7,001,926
- Issue date Feb 21, 2006
- OXiGENE, Inc.
- Kevin G. Pinney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functionalized stilbene derivatives as improved vascular targeting...
- Patent number 6,919,324
- Issue date Jul 19, 2005
- OXiGENE, Inc.
- David J. Chaplin
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NOVEL METHODS AND ANTIBODIES FOR TREATING CANCER
- Publication number 20140348833
- Publication date Nov 27, 2014
- GENMAB A/S
- Jan VAN DE WINKEL
- G01 - MEASURING TESTING
Information Patent Application
NOVEL METHODS AND ANTIBODIES FOR TREATING CANCER
- Publication number 20110256142
- Publication date Oct 20, 2011
- GENMAB A/S
- Jan Van De Winkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTION OF RASH IN PATIENTS UNDERGOING ANTI-EGFR THERAPY
- Publication number 20100150936
- Publication date Jun 17, 2010
- GENMAB A/S
- Klaus Edvardsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Functionalized stilbene derivatives as improved vascular targeting...
- Publication number 20060035868
- Publication date Feb 16, 2006
- David J. Chaplin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tubulin binding ligands and corresponding prodrug constructs
- Publication number 20040044059
- Publication date Mar 4, 2004
- Kevin G. Pinney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tubulin binding agents and corresponding prodrug constructs
- Publication number 20040043969
- Publication date Mar 4, 2004
- Kevin G. Pinney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Functionalized stilbene derivatives as improved vascular targeting...
- Publication number 20030149003
- Publication date Aug 7, 2003
- David J. Chaplin
- C07 - ORGANIC CHEMISTRY

Klaus EDVARDSEN

Person

Patents Grantslast 30 patents

Methods and antibodies for treating cancer

Method of treating rash in patients undergoing anti-EGFR therapy

Functionalized stilbene derivatives as improved vascular targeting...

Functionalized stilbene derivatives as improved vascular targeting...

Functionalized stilbene derivatives as improved vascular targeting...

Tubulin binding ligands and corresponding prodrug constructs

Tubulin binding agents and corresponding prodrug constructs

Functionalized stilbene derivatives as improved vascular targeting...

Patents Applicationslast 30 patents

NOVEL METHODS AND ANTIBODIES FOR TREATING CANCER

NOVEL METHODS AND ANTIBODIES FOR TREATING CANCER

PREVENTION OF RASH IN PATIENTS UNDERGOING ANTI-EGFR THERAPY

Functionalized stilbene derivatives as improved vascular targeting...

Tubulin binding ligands and corresponding prodrug constructs

Tubulin binding agents and corresponding prodrug constructs

Functionalized stilbene derivatives as improved vascular targeting...